Methods and apparatuses for determining an analyte value are disclosed.

Patent
   8216137
Priority
Oct 25 2006
Filed
Jul 20 2009
Issued
Jul 10 2012
Expiry
Aug 19 2027

TERM.DISCL.
Extension
298 days
Assg.orig
Entity
Large
43
621
all paid
1. A method, comprising:
monitoring a data stream associated with an analyte level;
generating a noise filtered signal associated with the data stream;
detecting a presence of a signal dropout based on the noise filtered signal; and
estimating, using one or more processors, a noise filtered dropout compensated signal based on the noise filtered signal and the determination of the presence of the signal dropout;
wherein generating the noise filtered signal is based on one or more previous noise filtered signals.
15. An apparatus, comprising:
one or more processors; and
a memory storing instructions which, when executed by the one or more processors, causes the one or more processors to monitor a data stream associated with an analyte level, to generate a noise filtered signal associated with the data stream based on one or more previous noise filtered signals, to detect a presence of a signal dropout based on the noise filtered signal, and to estimate a noise filtered dropout compensated signal based on the noise filtered signal and the determination of the presence of the signal dropout.
2. The method of claim 1 further comprising generating a signal associated with the detected presence of the signal dropout, wherein estimating the noise filtered dropout compensated signal includes determining a variation between the signal associated with the detected presence of the signal dropout and the generated noise filtered signal.
3. The method of claim 1 wherein estimating the noise filtered dropout compensated signal includes subtracting the signal associated with the detected presence of the signal dropout and the generated noise filtered signal.
4. The method of claim 1 wherein generating the noise filtered signal includes applying a filter to the data stream.
5. The method of claim 1 wherein generating the noise filtered signal includes applying a weighted average function to the data stream.
6. The method of claim 1 further including outputting the noise filtered dropout compensated signal, and wherein outputting the noise filtered dropout compensated signal includes providing an indication associated with the noise filtered signal.
7. The method of claim 1 including transmitting one or more of the monitored data stream, the noise filtered signal, the detected signal dropout, or the noise filtered dropout compensated signal.
8. The method of claim 7 wherein said transmitting includes wirelessly transmitting the one or more of the monitored data stream, the noise filtered signal, the detected signal dropout, or the noise filtered dropout compensated signal.
9. The method of claim 7 including transmitting the one or more of the monitored data stream, the noise filtered signal, the detected signal dropout, or the noise filtered dropout compensated signal to a remote location.
10. The method of claim 1 wherein monitoring the data stream includes detecting one or more signals from an analyte sensor.
11. The method of claim 10 wherein the analyte sensor includes a glucose sensor.
12. The method of claim 1 including receiving a reference measurement data.
13. The method of claim 12 wherein the reference measurement data includes a blood glucose measurement data.
14. The method of claim 12 including calibrating the noise filtered dropout compensated signal based on the received reference measurement data.
16. The apparatus of claim 15 wherein the memory stores instructions which, when executed by the one or more processors, causes the one or more processors to generate a signal associated with the detected presence of the signal dropout and to determine a variation between the signal associated with the detected presence of the signal dropout and the generated noise filtered signal.
17. The apparatus of claim 15 wherein the memory stores instructions which, when executed by the one or more processors, causes the one or more processors to subtract the signal associated with the detected presence of the signal dropout and the generated noise filtered signal.
18. The apparatus of claim 15 wherein the memory stores instructions which, when executed by the one or more processors, causes the one or more processors to apply a filter to the data stream.
19. The apparatus of claim 15 wherein the memory stores instructions which, when executed by the one or more processors, causes the one or more processors to apply a weighted average function to the data stream.
20. The apparatus of claim 15 wherein the memory stores instructions which, when executed by the one or more processors, causes the one or more processors to output the noise filtered dropout compensated signal.
21. The apparatus of claim 20 wherein the memory stores instructions which, when executed by the one or more processors, causes the one or more processors to provide an indication associated with the noise filtered signal.
22. The apparatus of claim 15 wherein the memory stores instructions which, when executed by the one or more processors, causes the one or more processors to transmit one or more of the monitored data stream, the noise filtered signal, the detected signal dropout, or the noise filtered dropout compensated signal.
23. The apparatus of claim 15 wherein the memory stores instructions which, when executed by the one or more processors, causes the one or more processors to detect one or more signals from an analyte sensor.
24. The apparatus of claim 23 wherein the analyte sensor includes a glucose sensor.
25. The apparatus of claim 15 wherein the memory stores instructions which, when executed by the one or more processors, causes the one or more processors to receive a reference measurement data.
26. The apparatus of claim 25 wherein the reference measurement data includes a blood glucose measurement data.
27. The apparatus of claim 25 wherein the memory stores instructions which, when executed by the one or more processors, causes the one or more processors to calibrate the noise filtered dropout compensated signal based on the received reference measurement data.

The present application is a continuation of U.S. patent application Ser. No. 11/552,935 filed Oct. 25, 2006, now U.S. Pat. No. 7,630,748, entitled “Method and System for Providing Analyte Monitoring,” the disclosure of which is incorporated herein by reference for all purposes.

Analyte, e.g., glucose monitoring systems including continuous and discrete monitoring systems generally include a small, lightweight battery powered and microprocessor controlled system which is configured to detect signals proportional to the corresponding measured glucose levels using an electrometer, and RF signals to transmit the collected data. One aspect of certain analyte monitoring systems include a transcutaneous or subcutaneous analyte sensor configuration which is, for example, partially mounted on the skin of a subject whose analyte level is to be monitored. The sensor cell may use a two or three-electrode (work, reference and counter electrodes) configuration driven by a controlled potential (potentiostat) analog circuit connected through a contact system.

The analyte sensor may be configured so that a portion thereof is placed under the skin of the patient so as to detect the analyte levels of the patient, and another segment of the analyte sensor that is in communication with the transmitter unit. The transmitter unit is configured to transmit the analyte levels detected by the sensor over a wireless communication link such as an RF (radio frequency) communication link to a receiver/monitor unit. The receiver/monitor unit performs data analysis, among others on the received analyte levels to generate information pertaining to the monitored analyte levels.

To obtain accurate data from the analyte sensor, calibration using capillary blood glucose measurements is necessary. Typically, blood glucose measurements are obtained using, for example, a blood glucose meter, and the measured blood glucose values are used to calibrate the sensors. Due to a lag factor between the monitored sensor data and the measured blood glucose values, an error, or signal noise such as signal dropouts, is typically introduced in calibration using the monitored data as well as in computing the displayed glucose value. While correcting for the lag factors can minimize the error due to lag in the presence of noise, in the presence of signal dropouts, such error compensation may reduce accuracy of the monitored sensor data.

In view of the foregoing, it would be desirable to have a method and system for providing noise filtering and signal dropout detection and/or compensation in data monitoring systems.

In one embodiment, a method for minimizing the effect of noise and signal dropouts in a glucose sensor including monitoring a data stream, generating a noise-filtered signal associated with the data stream, determining a presence of a signal dropout based on the noise filtered signal, and estimating a noise filtered dropout compensated signal based on the noise filtered signal and the determination of the presence of the signal dropout are disclosed.

These and other objects, features and advantages of the present invention will become more fully apparent from the following detailed description of the embodiments, the appended claims and the accompanying drawings.

FIG. 1 illustrates a block diagram of a data monitoring and management system for practicing one or more embodiments of the present invention;

FIG. 2 is a block diagram of the transmitter unit of the data monitoring and management system shown in FIG. 1 in accordance with one embodiment of the present invention;

FIG. 3 is a block diagram of the receiver/monitor unit of the data monitoring and management system shown in FIG. 1 in accordance with one embodiment of the present invention;

FIG. 4 is a functional diagram of the overall signal processing for noise filtering and signal dropout compensation in accordance with one embodiment of the present invention;

FIG. 5 is a flowchart illustrating the overall signal processing for noise filtering and signal dropout compensation in accordance with one embodiment of the present invention;

FIG. 6 is a flowchart illustrating the process input estimation in accordance with one embodiment of the present invention;

FIG. 7 is a flowchart illustrating the noise filtered estimation;

FIG. 8 is a flowchart illustrating signal dropout detection in accordance with one embodiment of the present invention;

FIG. 9 is a flowchart illustrating an overall signal dropout compensation in accordance with one embodiment of the present invention; and

FIG. 10 is flowchart illustrating a detailed signal dropout compensation determination of FIG. 9 in accordance with one embodiment of the present invention.

As described in further detail below, in accordance with the various embodiments of the present invention, there is provided a method and system for providing noise filtered and/or signal dropout mitigated processes for signals in analyte monitoring systems. In particular, within the scope of the present invention, there are provided method and system for noise filtering, signal dropout detection, and signal dropout compensation to improve the accuracy of lag compensation.

FIG. 1 illustrates a data monitoring and management system such as, for example, analyte (e.g., glucose) monitoring system 100 in accordance with one embodiment of the present invention. The subject invention is further described primarily with respect to a glucose monitoring system for convenience and such description is in no way intended to limit the scope of the invention. It is to be understood that the analyte monitoring system may be configured to monitor a variety of analytes, e.g., lactate, and the like.

Analytes that may be monitored include, for example, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be monitored.

The analyte monitoring system 100 includes a sensor 101, a transmitter unit 102 coupled to the sensor 101, and a primary receiver unit 104 which is configured to communicate with the transmitter unit 102 via a communication link 103. The primary receiver unit 104 may be further configured to transmit data to a data processing terminal 105 for evaluating the data received by the primary receiver unit 104. Moreover, the data processing terminal in one embodiment may be configured to receive data directly from the transmitter unit 102 via a communication link which may optionally be configured for bi-directional communication.

Also shown in FIG. 1 is a secondary receiver unit 106 which is operatively coupled to the communication link and configured to receive data transmitted from the transmitter unit 102. Moreover, as shown in the Figure, the secondary receiver unit 106 is configured to communicate with the primary receiver unit 104 as well as the data processing terminal 105. Indeed, the secondary receiver unit 106 may be configured for bi-directional wireless communication with each of the primary receiver unit 104 and the data processing terminal 105. As discussed in further detail below, in one embodiment of the present invention, the secondary receiver unit 106 may be configured to include a limited number of functions and features as compared with the primary receiver unit 104. As such, the secondary receiver unit 106 may be configured substantially in a smaller compact housing or embodied in a device such as a wrist watch, for example. Alternatively, the secondary receiver unit 106 may be configured with the same or substantially similar functionality as the primary receiver unit 104, and may be configured to be used in conjunction with a docking cradle unit for placement by bedside, for night time monitoring, and/or bi-directional communication device.

Only one sensor 101, transmitter unit 102, communication link 103, and data processing terminal 105 are shown in the embodiment of the analyte monitoring system 100 illustrated in FIG. 1. However, it will be appreciated by one of ordinary skill in the art that the analyte monitoring system 100 may include one or more sensor 101, transmitter unit 102, communication link 103, and data processing terminal 105. Moreover, within the scope of the present invention, the analyte monitoring system 100 may be a continuous monitoring system, or semi-continuous, or a discrete monitoring system. In a multi-component environment, each device is configured to be uniquely identified by each of the other devices in the system so that communication conflict is readily resolved between the various components within the analyte monitoring system 100.

In one embodiment of the present invention, the sensor 101 is physically positioned in or on the body of a user whose analyte level is being monitored. The sensor 101 may be configured to continuously sample the analyte level of the user and convert the sampled analyte level into a corresponding data signal for transmission by the transmitter unit 102. In one embodiment, the transmitter unit 102 is mounted on the sensor 101 so that both devices are positioned on the user's body. The transmitter unit 102 performs data processing such as filtering and encoding on data signals, each of which corresponds to a sampled analyte level of the user, for transmission to the primary receiver unit 104 via the communication link 103.

In one embodiment, the analyte monitoring system 100 is configured as a one-way RF communication path from the transmitter unit 102 to the primary receiver unit 104. In such embodiment, the transmitter unit 102 transmits the sampled data signals received from the sensor 101 without acknowledgement from the primary receiver unit 104 that the transmitted sampled data signals have been received. For example, the transmitter unit 102 may be configured to transmit the encoded sampled data signals at a fixed rate (e.g., at one minute intervals) after the completion of the initial power on procedure. Likewise, the primary receiver unit 104 may be configured to detect such transmitted encoded sampled data signals at predetermined time intervals. Alternatively, the analyte monitoring system 100 may be configured with a bi-directional RF (or otherwise) communication between the transmitter unit 102 and the primary receiver unit 104.

Additionally, in one aspect, the primary receiver unit 104 may include two sections. The first section is an analog interface section that is configured to communicate with the transmitter unit 102 via the communication link 103. In one embodiment, the analog interface section may include an RF receiver and an antenna for receiving and amplifying the data signals from the transmitter unit 102, which are thereafter, demodulated with a local oscillator and filtered through a band-pass filter. The second section of the primary receiver unit 104 is a data processing section which is configured to process the data signals received from the transmitter unit 102 such as by performing data decoding, error detection and correction, data clock generation, and data bit recovery.

In operation, upon completing the power-on procedure, the primary receiver unit 104 is configured to detect the presence of the transmitter unit 102 within its range based on, for example, the strength of the detected data signals received from the transmitter unit 102 or a predetermined transmitter identification information. Upon successful synchronization with the corresponding transmitter unit 102, the primary receiver unit 104 is configured to begin receiving from the transmitter unit 102 data signals corresponding to the user's detected analyte level. More specifically, the primary receiver unit 104 in one embodiment is configured to perform synchronized time hopping with the corresponding synchronized transmitter unit 102 via the communication link 103 to obtain the user's detected analyte level.

Referring again to FIG. 1, the data processing terminal 105 may include a personal computer, a portable computer such as a laptop or a handheld device (e.g., personal digital assistants (PDAs)), and the like, each of which may be configured for data communication with the receiver via a wired or a wireless connection. Additionally, the data processing terminal 105 may further be connected to a data network (not shown) for storing, retrieving and updating data corresponding to the detected analyte level of the user.

Within the scope of the present invention, the data processing terminal 105 may include an infusion device such as an insulin infusion pump or the like, which may be configured to administer insulin to patients, and which may be configured to communicate with the receiver unit 104 for receiving, among others, the measured analyte level. Alternatively, the receiver unit 104 may be configured to integrate an infusion device therein so that the receiver unit 104 is configured to administer insulin therapy to patients, for example, for administering and modifying basal profiles, as well as for determining appropriate boluses for administration based on, among others, the detected analyte levels received from the transmitter unit 102.

Additionally, the transmitter unit 102, the primary receiver unit 104 and the data processing terminal 105 may each be configured for bi-directional wireless communication such that each of the transmitter unit 102, the primary receiver unit 104 and the data processing terminal 105 may be configured to communicate (that is, transmit data to and receive data from) with each other via the wireless communication link 103. More specifically, the data processing terminal 105 may in one embodiment be configured to receive data directly from the transmitter unit 102 via the communication link, where the communication link, as described above, may be configured for bi-directional communication.

In this embodiment, the data processing terminal 105 which may include an insulin pump, may be configured to receive the analyte signals from the transmitter unit 102, and thus, incorporate the functions of the receiver 104 including data processing for managing the patient's insulin therapy and analyte monitoring. In one embodiment, the communication link 103 may include one or more of an RF communication protocol, an infrared communication protocol, a Bluetooth enabled communication protocol, an 802.11x wireless communication protocol, or an equivalent wireless communication protocol which would allow secure, wireless communication of several units (for example, per HIPAA requirements) while avoiding potential data collision and interference.

FIG. 2 is a block diagram of the transmitter of the data monitoring and detection system shown in FIG. 1 in accordance with one embodiment of the present invention. Referring to the Figure, the transmitter unit 102 in one embodiment includes an analog interface 201 configured to communicate with the sensor 101 (FIG. 1), a user input 202, and a temperature detection section 203, each of which is operatively coupled to a transmitter processor 204 such as a central processing unit (CPU). As can be seen from FIG. 2, there are provided four contacts, three of which are electrodes—work electrode (W), guard contact (G), reference electrode (R), and counter electrode (C), each operatively coupled to the analog interface 201 of the transmitter unit 102 for connection to the sensor unit 201 (FIG. 1). In one embodiment, each of the work electrode (W), guard contact (G), reference electrode (R), and counter electrode (C) may be made using a conductive material that is either printed or etched, for example, such as carbon which may be printed, or metal foil (e.g., gold) which may be etched.

Further shown in FIG. 2 are a transmitter serial communication section 205 and an RF transmitter 206, each of which is also operatively coupled to the transmitter processor 204. Moreover, a power supply 207 such as a battery is also provided in the transmitter unit 102 to provide the necessary power for the transmitter unit 102. Additionally, as can be seen from the Figure, clock 208 is provided to, among others, supply real time information to the transmitter processor 204.

In one embodiment, a unidirectional input path is established from the sensor 101 (FIG. 1) and/or manufacturing and testing equipment to the analog interface 201 of the transmitter unit 102, while a unidirectional output is established from the output of the RF transmitter 206 of the transmitter unit 102 for transmission to the primary receiver unit 104. In this manner, a data path is shown in FIG. 2 between the aforementioned unidirectional input and output via a dedicated link 209 from the analog interface 201 to serial communication section 205, thereafter to the processor 204, and then to the RF transmitter 206. As such, in one embodiment, via the data path described above, the transmitter unit 102 is configured to transmit to the primary receiver unit 104 (FIG. 1), via the communication link 103 (FIG. 1), processed and encoded data signals received from the sensor 101 (FIG. 1). Additionally, the unidirectional communication data path between the analog interface 201 and the RF transmitter 206 discussed above allows for the configuration of the transmitter unit 102 for operation upon completion of the manufacturing process as well as for direct communication for diagnostic and testing purposes.

As discussed above, the transmitter processor 204 is configured to transmit control signals to the various sections of the transmitter unit 102 during the operation of the transmitter unit 102. In one embodiment, the transmitter processor 204 also includes a memory (not shown) for storing data such as the identification information for the transmitter unit 102, as well as the data signals received from the sensor 101. The stored information may be retrieved and processed for transmission to the primary receiver unit 104 under the control of the transmitter processor 204. Furthermore, the power supply 207 may include a commercially available battery.

The transmitter unit 102 is also configured such that the power supply section 207 is capable of providing power to the transmitter for a minimum of about three months of continuous operation after having been stored for about eighteen months in a low-power (non-operating) mode. In one embodiment, this may be achieved by the transmitter processor 204 operating in low power modes in the non-operating state, for example, drawing no more than approximately 1 HA of current. Indeed, in one embodiment, the final step during the manufacturing process of the transmitter unit 102 may place the transmitter unit 102 in the lower power, non-operating state (i.e., post-manufacture sleep mode). In this manner, the shelf life of the transmitter unit 102 may be significantly improved. Moreover, as shown in FIG. 2, while the power supply unit 207 is shown as coupled to the processor 204, and as such, the processor 204 is configured to provide control of the power supply unit 207, it should be noted that within the scope of the present invention, the power supply unit 207 is configured to provide the necessary power to each of the components of the transmitter unit 102 shown in FIG. 2.

Referring back to FIG. 2, the power supply section 207 of the transmitter unit 102 in one embodiment may include a rechargeable battery unit that may be recharged by a separate power supply recharging unit (for example, provided in the receiver unit 104) so that the transmitter unit 102 may be powered for a longer period of usage time. Moreover, in one embodiment, the transmitter unit 102 may be configured without a battery in the power supply section 207, in which case the transmitter unit 102 may be configured to receive power from an external power supply source (for example, a battery) as discussed in further detail below.

Referring yet again to FIG. 2, the temperature detection section 203 of the transmitter unit 102 is configured to monitor the temperature of the skin near the sensor insertion site. The temperature reading is used to adjust the analyte readings obtained from the analog interface 201. The RF transmitter 206 of the transmitter unit 102 may be configured for operation in the frequency band of 315 MHz to 322 MHz, for example, in the United States. Further, in one embodiment, the RF transmitter 206 is configured to modulate the carrier frequency by performing Frequency Shift Keying and Manchester encoding. In one embodiment, the data transmission rate is 19,200 symbols per second, with a minimum transmission range for communication with the primary receiver unit 104.

Referring yet again to FIG. 2, not shown is a leak detection circuit coupled to the guard electrode (G) and the processor 204 in the transmitter unit 102 of the data monitoring and management system 100. The leak detection circuit in accordance with one embodiment of the present invention may be configured to detect leakage current in the sensor 101 to determine whether the measured sensor data are corrupt or whether the measured data from the sensor 101 is accurate.

Additional detailed description of the continuous analyte monitoring system, its various components including the functional descriptions of the transmitter are provided in U.S. Pat. No. 6,175,752 issued Jan. 16, 2001 entitled “Analyte Monitoring Device and Methods of Use”, and in application Ser. No. 10/745,878 filed Dec. 26, 2003 entitled “Continuous Glucose Monitoring System and Methods of Use”, each assigned to the Assignee of the present application.

FIG. 3 is a block diagram of the receiver/monitor unit of the data monitoring and management system shown in FIG. 1 in accordance with one embodiment of the present invention. Referring to FIG. 3, the primary receiver unit 104 includes a blood glucose test strip interface 301, an RF receiver 302, an input 303, a temperature detection section 304, and a clock 305, each of which is operatively coupled to a receiver processor 307. As can be further seen from the Figure, the primary receiver unit 104 also includes a power supply 306 operatively coupled to a power conversion and monitoring section 308. Further, the power conversion and monitoring section 308 is also coupled to the receiver processor 307. Moreover, also shown are a receiver serial communication section 309, and an output 310, each operatively coupled to the receiver processor 307.

In one embodiment, the test strip interface 301 includes a glucose level testing portion to receive a manual insertion of a glucose test strip, and thereby determine and display the glucose level of the test strip on the output 310 of the primary receiver unit 104. This manual testing of glucose can be used to calibrate sensor 101. The RF receiver 302 is configured to communicate, via the communication link 103 (FIG. 1) with the RF transmitter 206 of the transmitter unit 102, to receive encoded data signals from the transmitter unit 102 for, among others, signal mixing, demodulation, and other data processing. The input 303 of the primary receiver unit 104 is configured to allow the user to enter information into the primary receiver unit 104 as needed. In one aspect, the input 303 may include one or more keys of a keypad, a touch-sensitive screen, or a voice-activated input command unit. The temperature detection section 304 is configured to provide temperature information of the primary receiver unit 104 to the receiver processor 307, while the clock 305 provides, among others, real time information to the receiver processor 307.

Each of the various components of the primary receiver unit 104 shown in FIG. 3 is powered by the power supply 306 which, in one embodiment, includes a battery. Furthermore, the power conversion and monitoring section 308 is configured to monitor the power usage by the various components in the primary receiver unit 104 for effective power management and to alert the user, for example, in the event of power usage which renders the primary receiver unit 104 in sub-optimal operating conditions. An example of such sub-optimal operating condition may include, for example, operating the vibration output mode (as discussed below) for a period of time thus substantially draining the power supply 306 while the processor 307 (thus, the primary receiver unit 104) is turned on. Moreover, the power conversion and monitoring section 308 may additionally be configured to include a reverse polarity protection circuit such as a field effect transistor (FET) configured as a battery activated switch.

The serial communication section 309 in the primary receiver unit 104 is configured to provide a bi-directional communication path from the testing and/or manufacturing equipment for, among others, initialization, testing, and configuration of the primary receiver unit 104. Serial communication section 309 can also be used to upload data to a computer, such as time-stamped blood glucose data. The communication link with an external device (not shown) can be made, for example, by cable, infrared (IR) or RF link. The output 310 of the primary receiver unit 104 is configured to provide, among others, a graphical user interface (GUI) such as a liquid crystal display (LCD) for displaying information. Additionally, the output 310 may also include an integrated speaker for outputting audible signals as well as to provide vibration output as commonly found in handheld electronic devices, such as mobile telephones presently available. In a further embodiment, the primary receiver unit 104 also includes an electro-luminescent lamp configured to provide backlighting to the output 310 for output visual display in dark ambient surroundings.

Referring back to FIG. 3, the primary receiver unit 104 in one embodiment may also include a storage section such as a programmable, non-volatile memory device as part of the processor 307, or provided separately in the primary receiver unit 104, operatively coupled to the processor 307. The processor 307 is further configured to perform Manchester decoding as well as error detection and correction upon the encoded data signals received from the transmitter unit 102 via the communication link 103.

FIG. 4 is a functional diagram of the overall signal processing for noise filtering and signal dropout compensation, while FIG. 5 shows a flowchart illustrating the overall signal processing for noise filtering and signal dropout compensation in accordance with one embodiment of the present invention. Referring to the Figures, in one embodiment, signals measured are received from, for example, the analyte sensor 101 (FIG. 1) and are provided to the state observer 410 which in one embodiment may be configured to provide prior or past noise filtered estimate to a process input estimator 420.

In one embodiment, the process input estimator 420 may be configured to generate a process input estimate based on the prior or past noise filtered estimate of the received or measured signal (510), which is then provided to the state observer 410. In one aspect, and as described in further detail below in conjunction with FIG. 6, the process input estimate at a predetermined time t may be based on past noise filtered estimate of the signal.

Thereafter, in one embodiment, the state observer 410 may be configured to generate a noise filtered estimate of the measured or received signal based on the current measured or received signal and the process input estimate (520) received from the process input estimator 420. In one embodiment and as described in further detail below in conjunction with FIG. 7, using the real time process input and sensor measurement signals, a noise filtered estimate of the signal at the latest time t may be determined.

In one aspect, this routine of generating the process input estimate based on the past noise filtered estimate of the received or measured signal, and generating the noise filtered estimate of the signal based on the current received or measured signal and the current determined or generated process input estimate may be repeated for each measurement signal received, for example, from the analyte sensor 101 (FIG. 1). In this manner, in one aspect, the noise filtered signals corresponding to the measured or received sensor signals may be determined.

Referring back to FIGS. 4 and 5, in one embodiment, with the noise filtered estimate, the presence of signal dropouts are detected based on, for example, the current and past noise filtered estimate of the received or measured signal (530). More specifically, in one embodiment, a dropout detector 430 may be configured to detect signal dropouts, and thereafter, detection of signal dropouts are provided to dropout compensator 440. In one aspect, the dropout detector 430 may be configured to generate a signal or notification associated with the detection of a signal dropout (as shown in FIG. 4). That is, in one embodiment and as described in further detail below in conjunction with FIG. 8, the dropout detector 430 may be configured to detect or estimate the presence or absence of signal dropouts at the predetermined time.

In one embodiment, the dropout compensator 440 may be configured to generate an estimate of the noise filtered, dropout compensated signal (540) when the signal dropout is detected (for example, by the dropout detector 430), by subtracting the estimate of the current dropout signal source from the present noise filtered estimate of the signal. In this manner, and as described in further detail below in conjunction with FIGS. 9-10, in one embodiment of the present invention, the noise filtered signal dropout mitigated or compensated signal may be generated to improve accuracy of the measured or received signal from, for example, the analyte sensor 101 (FIG. 1).

FIG. 6 is a flowchart illustrating the process input estimation in accordance with one embodiment of the present invention. Referring to FIG. 6, a mean component of the process input estimate um(t) based on past noise filtered estimate of the signal is generated (610). For example, in one embodiment, a series of five past noise-filtered estimate of the signal, xi(t−5), xi(t−4), xi(t−3), xi(t−2), xi(t−1), the mean component of the process input estimate at time t, um(t) may be determined by taking the unweighted average of these signals as shown by the following relationship:

u m ( t ) = x i ( t - 5 ) + x i ( t - 4 ) + x i ( t - 3 ) + x i ( t - 2 ) + x i ( t - 1 ) 5 ( 1 )

Alternatively, the mean component of the process input estimate at time t may be determined by taking the weighted average of these signals as shown by the following relationship:

u m ( t ) = a 5 x i ( t - 5 ) + a 4 x i ( t - 4 ) + a 3 x i ( t - 3 ) + a 2 x i ( t - 2 ) + a 1 x i ( t - 1 ) a 5 + a 4 + a 3 + a 2 + a 1 ( 2 )

where the determination of the constants a1, a2, a3, a4, a5, may be obtained based on empirical or analytical analysis of the analyte monitoring system.

In yet another embodiment, the mean component of the process input estimate at time t based on recent past data may be determined using filtering techniques, such as, but not limited to FIR filters.

Referring to FIG. 6, with the mean component of the process input estimate um(t) based on past noise filtered estimate of the signal determined, the difference component of the process input estimate at any time t, ud(t), may be generated (620) by, for example, taking an averaged difference of a series of noise-filtered estimate of the signal from the recent past. In one aspect, an unweighted average of the last three past differences may be used in the following manner:

u d ( t ) = ( x i ( t - 4 ) - x i ( t - 3 ) ) + ( x i ( t - 3 ) - x i ( t - 2 ) ) + ( x i ( t - 2 ) - x i ( t - 1 ) ) 3 ( 3 )

Within the scope of the present invention, other approaches such as the use of FIR filter to determine the proper number of recent past values of xi as well as the weighting of each difference may be used.

Referring again to FIG. 6, after determining the difference component of the process input estimate at any time t, ud(t), the difference gain at any time t, Kd(t), is determined (630), for example, by using past noise-filtered estimate of the signal, xi, and/or the derived signals from xi. For example, in one embodiment, a band-limited rate xibandRate and a band-limited acceleration xibandAcc may be determined at any time t, based solely on recent past values of xi. Using the knowledge of how the amount of ud would contribute to the total process input u at any time t relates to these two variables xibandRate and xibandAcc, a functional relationship may be determined to ascertain the value of the difference gain Kd at any time t.

Alternatively, a lookup table can be constructed that determines the value of the difference gain Kd given the values of xibandRate and xibandAcc as shown below:

K d = { 2 if ( x i_bandRate > 0 ) & ( x i_bandAcc > 0 ) 1 if ( x i_bandRate > 0 ) & ( x i_bandAcc 0 ) 1 if ( x i_bandRate 0 ) & ( x i_bandAcc 0 ) 0.5 if ( x i_bandRate 0 ) & ( x i_bandAcc > 0 ) ( 4 )

In one aspect, the difference gain Kd may be used to scale the contribution of the difference component of the process input estimate ud in the value of the process input estimate at a given time. For example, a relatively larger value of the difference gain Kd may indicate a larger contribution of the difference component of the process input estimate ud in the value of the process input estimate at the particular time, and so on. In this manner, in one aspect, the lookup table may show the relationship between factors such as the band-limited rate xibandRate and the band-limited acceleration xibandAce upon how much the difference component of the process input estimate ud should contribute to the process input estimate value.

Referring again to FIG. 6, with the mean component of the process input estimate um(t), the difference component of the process input estimate at any time t, ud(t), and the difference gain at any time t, Kd(t), the scaled difference component uds(t) of the process input estimate may be determined (640) by multiplying the difference component of the process input estimate at any time t, ud(t) by the difference gain at any time t, Kd(t). Thereafter, the scaled difference component uds(t) of the process input estimate may be added to the mean component of the process input estimate um(t) to determine the current process input estimate value u(t) (650).

FIG. 7 is a flowchart illustrating the noise filtered estimation. Referring to FIG. 7, with an estimate of process input signal at any time t, u(t), and based on the measured signals from the analyte sensor z(t), in addition to past estimates of the noise-filtered signal xi(t−1), xi(t−2), . . . , the state observer 410 (FIG. 4) may be configured to determine the estimate of noise-filtered signal at any time t, xi(t). In one aspect, the state observer 410 (FIG. 4) may be configured to reduce the contribution of noise without introducing excessive undesirable distortion based on the estimate of process input signal at any time t, u(t), and the measured signals from the sensor z(t).

FIG. 8 is a flowchart illustrating signal dropout detection in accordance with one embodiment of the present invention. Referring to FIG. 8, a present “fast rate” estimate Xdf(t) is determined based on present and past noise-filtered estimate of the signal (810). For example, a difference signal xd(t) may be determined based on the following expression:
xd(t)=xi(t)−xi(t−1)  (5)
Thereafter, a fast rate may be extracted from the difference signal xd(t) by performing high pass filtering on the difference signal xd(t). In one embodiment, a discrete-time realization of a first order high pass filter function may be used to determine the present “fast rate” estimate Xdf(t):
xdf(t)=αhpfDxdf(t−1)+xd(t)−xd(t−1)  (6)

where the value of ahpfD, or the structure of the high pass filter may be determined in accordance with the suitable design configurations, for example, a value between zero and one.

Referring back to FIG. 8, after determining the “fast rate” estimate xdf(t), a present “slow rate” estimate xds(t) is determined based on present and past noise-filtered estimate of the signal (820). For example, in one embodiment, the slow rate estimate xds(t) may be determined by passing the simple difference through a low-pass filter, or alternatively, by taking the difference between the simple difference and the fast difference signals as shown, for example, by the following expression:
xds(t)=xd(t)−xdf(t)  (7)

After determining the slow rate estimate xds(t), it is determined whether there is a beginning of a large negative spike in the fast rate estimate xdf(t) (830). That is, referring to FIG. 8, the start of a signal dropout state is determined which is correlated to a spike in the fast difference. The fast difference does not generate a spike larger than a predetermined value in response to signals generated in the absence of dropouts. For example, adjusted to the units of glucose concentration, this may correspond to a fast rate in excess of −3 mg/(dL min). Although a rate of −3 mg/(dL min) or faster may be ascertained, when band pass filtered, the fast rate estimate xdf(t) determined above does not occur in this range unless a signal dropout occurs.

Referring back to FIG. 8, if the beginning of a large negative spike in the fast rate estimate xdf(t) is detected, then the elapsed time period from the initial occurrence of the large negative spike is monitored (840), for example, by triggering a timer or a counter so as to monitor the elapsed time since the most recent signal dropout occurrence predicted estimate. In this manner, a safety check mechanism may be provided to determine situations where a signal dropout that was anticipated to have started has lasted in an undesirably long period of dropout time period. That is, as the signal dropouts are generally intermittent in nature, it is expected that the dropout does not last beyond the order of one hour, for example, and more commonly, in the order of five to 30 minutes.

Thereafter, it is determined whether a predetermined allowable time period has elapsed (850). As shown in FIG. 8, if it is determined the allowable time period has not elapsed, then the beginning or onset of the signal dropout is estimated. On the other hand, if the predetermined allowable time period has elapsed, then the end of the signal dropout is estimated. Referring again to FIG. 8, when the beginning of a large negative spike in the fast rate estimate xdf(t) is not detected, it is determined whether an end of a large positive spike (for example, in the order of +3 mg/(dL min)) in the fast rate estimate xdf(t) is detected (860). If the end of the large positive spike in the fast rate estimate xdf(t) is detected, then the end of the signal dropout is estimated. On the other hand, if the end of the large positive spike in the fast rate estimate xdf(t) is not detected, then no signal dropout is estimated.

That is, a signal dropout is generally correlated to a large positive spike in the fast difference. Thus, in this case, the tail of the large positive spike is monitored and detected as the end of the signal dropout. In one embodiment, this maximizes the likelihood of detecting most of the instances within a signal dropout.

In this manner, in one embodiment of the present invention, the presence of signal dropout may be monitored and detected based on, for example, present and past noise filtered estimate of the signals.

FIG. 9 is a flowchart illustrating an overall signal dropout compensation in accordance with one embodiment of the present invention. Referring to FIG. 9, a momentum-based estimate is determined based on the present slow difference and previous momentum-based estimate (910). That is, with the present and past noise filtered estimate of the signal, the present and past slow and fast rate estimates determined as described above, and with the signal dropout detection estimation determined above, the momentum-based estimate is determined based on the present slow difference and previous momentum-based estimate. That is, in one embodiment, a momentum-based estimate may factor in a signal without dropouts as being likely to project (e.g., extrapolate) based on its past signal and its prior trend.

Referring back to FIG. 9, after determining the momentum based estimate using the present slow difference and prior momentum-based estimate, an averaged value of the present or current momentum-based estimate and the present noise filtered estimate is determined (920). Thereafter, an inertial gain based on the present and past slow rate estimate is determined (930), and which may be configured to scale the contribution of the momentum-based estimate determined using the present slow different and the previous momentum based estimate above in the final dropout compensated gain. Referring again to FIG. 9, after determining the inertial gain, a tracking gain is determined based on the inertial gain (940). In one embodiment, the determined tracking gain may be configured to scale the impact of the determined average value of the present momentum-based estimate and the present noise-filtered estimate, in the determination of the final dropout compensated signal (950) as discussed below.

Referring to FIG. 9, after determining the tracking gain, the dropout compensated signal is determined (950). In one embodiment, the dropout-compensated signal equals the noise-filtered estimate of the signal xi, when no dropout is estimated. Otherwise, the dropout compensated signal may be a weighted average of the momentum-based estimate (xmomentum) as discussed above and the averaged momentum and noise-filtered estimate (xaverage) also discussed above. In one aspect, the weighing factors for the weighted average of the momentum-based estimate (xmomentum) and the averaged momentum and noise-filtered estimate (xaverage) may be the inertial gain Kinertial and tracking gain Ktracking, respectively. For example, the dropout compensated signal at any time t, x′dci(t) in one embodiment may be determined in accordance with the following relationship:
x′dci(t)=(Kinertial(t)xmomentum(t))+(Ktracking(t)xaverage(t))  (8)

In a further embodiment, the determination of the dropout compensated signal at any time t, x′dci(t) may be refined to ensure a smooth transition depending upon the underlying conditions, as described in further detail below in conjunction with FIG. 10.

Referring back to FIG. 9, after determining the dropout compensated signal, the dropout compensated signal may be clipped to be within a predetermined range (960), for example, such that the dropout compensated signal is not less than the noise-filtered signal, and further, that it is not greater than a specified safety ratio times the noise-filtered signal.

In certain cases, the resulting value of the dropout compensated signal x′dci(t) may fall below the noise-filtered estimate xi(t). Since by definition, a dropout is a phenomena that can only reduce the true value of a signal, the relationship (8) above for determining the dropout compensated signal may be modified by ensuring that its value never goes below xi(t) at any given time, and as shown by the following expression:

x dci ( t ) = { x dci ( t ) for x dci ( t ) x i ( t ) x i ( t ) for x dci ( t ) < x i ( t ) ( 9 )

FIG. 10 is flowchart illustrating a detailed signal dropout compensation determination of FIG. 9 in accordance with one embodiment of the present invention. Referring to FIG. 10, for example, in determining the drop-compensated signal, it is first determined whether signal dropout is detected. If signal dropout is not detected, then it is determined whether a preset time period has elapsed since the end of the last dropout occurrence. If it is determined that a preset time period has elapsed, then the dropout compensated signal may be based upon the present noise filtered signal. In one aspect, the preset time period may be a predetermined time period that may be considered a long period of time. On the other hand, if it is determined that the preset time period has not elapsed (that is, the end of the occurrence of a signal dropout has recently occurred), then the dropout compensated signal may be based upon a smooth transition using the previous dropout compensated signal and the present noise filtered signal.

Indeed, referring to FIG. 10, it can be seen that depending upon the determination of the timing of the signal dropout occurrence, in particular embodiments, the dropout compensated signal may be determined based on one or more factors as shown in the Figure and also described above.

Referring again to the Figures, in particular embodiments, the processings associated with the noise filtering, signal dropout detection estimation and compensation may be performed by one or more processing units of the one or more receiver unit (104, 106) the transmitter unit 102 or the data processing terminal/infusion section 105. In addition, the one or more of the transmitter unit 102, the primary receiver unit 104, secondary receiver unit 106, or the data processing terminal/infusion section 105 may also incorporate a blood glucose meter functionality, such that, the housing of the respective one or more of the transmitter unit 102, the primary receiver unit 104, secondary receiver unit 106, or the data processing terminal/infusion section 105 may include a test strip port configured to receive a blood sample for determining one or more blood glucose levels of the patient.

In a further embodiment, the one or more of the transmitter unit 102, the primary receiver unit 104, secondary receiver unit 106, or the data processing terminal/infusion section 105 may be configured to receive the blood glucose value wirelessly over a communication link from, for example, a glucose meter. In still a further embodiment, the user or patient manipulating or using the analyte monitoring system 100 (FIG. 1) may manually input the blood glucose value using, for example, a user interface (for example, a keyboard, keypad, and the like) incorporated in the one or more of the transmitter unit 102, the primary receiver unit 104, secondary receiver unit 106, or the data processing terminal/infusion section 105.

A method in one embodiment includes monitoring a data stream, generating a noise-filtered signal associated with the data stream, detecting a presence of a signal dropout based on the noise filtered signal, and estimating a noise filtered dropout compensated signal based on the noise filtered signal and the determination of the presence of the signal dropout.

In one aspect, generating the noise filtered signal may include generating one or more frequency-shaped signals based on the monitored data stream, and further, which may include high pass filtering the monitored data stream.

Also, generating the noise filtered signal in another aspect may be based on one or more previous noise filtered signals.

The method in a further embodiment may include outputting the noise filtered signal. The method in still another aspect may include outputting the noise filtered dropout compensated signal.

The method may also include generating a signal associated with detecting the presence of a signal dropout.

Moreover, the data stream in one embodiment may be associated with a monitored analyte levels of a patient.

An apparatus in another embodiment includes one or more processors, and a memory for storing instructions which, when executed by the one or more processors, causes the one or more processors to monitor a data stream, generate a noise-filtered signal associated with the data stream, detect a presence of a signal dropout based on the noise filtered signal, and estimate a noise filtered dropout compensated signal based on the noise filtered signal and the determination of the presence of the signal dropout.

The memory may be further configured for storing instructions which, when executed by the one or more processors, causes the one or more processors to generate one or more frequency-shaped signals based on the monitored data stream.

In another aspect, the memory may be further configured for storing instructions which, when executed by the one or more processors, causes the one or more processors to generate the one or more frequency shaped signals by high pass filtering the monitored data stream.

In still another aspect, the memory may be further configured for storing instructions which, when executed by the one or more processors, causes the one or more processors to generate the noise filtered signal based on one or more previous noise filtered signals.

Moreover, the memory may be further configured for storing instructions which, when executed by the one or more processors, causes the one or more processors to output the noise filtered signal.

In yet another embodiment, the memory may be further configured for storing instructions which, when executed by the one or more processors, causes the one or more processors to output the noise filtered dropout compensated signal.

Additionally, the memory may be further configured for storing instructions which, when executed by the one or more processors, causes the one or more processors to generate a signal associated with detecting the presence of a signal dropout.

A system in accordance with still another embodiment may include an analyte sensor configured to monitor an analyte of a patient, a data processing section operatively coupled to the analyte sensor, the data processing section further including one or more processors, and a memory for storing instructions which, when executed by the one or more processors, causes the one or more processors to monitor a data stream, generate a noise-filtered signal associated with the data stream, detect a presence of a signal dropout based on the noise filtered signal, and estimate a noise filtered dropout compensated signal based on the noise filtered signal and the determination of the presence of the signal dropout.

The data processing section may include a data transmission unit operatively coupled to one or more processors configured to transmit the data stream. In another aspect, the data processing section may include a data receiving unit operatively coupled to the one or more processors and configured to receive the data stream.

The analyte sensor may include a glucose sensor.

Moreover, the memory may be further configured for storing instructions which, when executed by the one or more processors, causes the one or more processors to store one or more of the data stream, the noise filtered signal, or the noise filtered dropout compensated signal.

The various processes described above including the processes performed by the receiver unit 104/106 or transmitter unit 102 in the software application execution environment in the analyte monitoring system 100 including the processes and routines described in conjunction with FIGS. 5-10, may be embodied as computer programs developed using an object oriented language that allows the modeling of complex systems with modular objects to create abstractions that are representative of real world, physical objects and their interrelationships. The software required to carry out the inventive process, which may be stored in the memory or storage unit of the receiver unit 104/106 or transmitter unit 102 may be developed by a person of ordinary skill in the art and may include one or more computer program products.

Various other modifications and alterations in the structure and method of operation of this invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. It is intended that the following claims define the scope of the present invention and that structures and methods within the scope of these claims and their equivalents be covered thereby.

Budiman, Erwin S.

Patent Priority Assignee Title
10076285, Mar 15 2013 Abbott Diabetes Care Inc Sensor fault detection using analyte sensor data pattern comparison
10089446, Jan 29 2009 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
10092229, Jun 29 2010 Abbott Diabetes Care Inc Calibration of analyte measurement system
10117606, Oct 30 2009 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
10188334, Oct 30 2012 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
10194868, Oct 25 2006 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
10433773, Mar 15 2013 Abbott Diabetes Care Inc Noise rejection methods and apparatus for sparsely sampled analyte sensor data
10555695, Apr 15 2011 DexCom, Inc. Advanced analyte sensor calibration and error detection
10561354, Apr 15 2011 DexCom, Inc. Advanced analyte sensor calibration and error detection
10610141, Apr 15 2011 DexCom, Inc. Advanced analyte sensor calibration and error detection
10624568, Apr 15 2011 DexCom, Inc. Advanced analyte sensor calibration and error detection
10682084, Apr 15 2011 DexCom, Inc. Advanced analyte sensor calibration and error detection
10722162, Apr 15 2011 DexCom, Inc. Advanced analyte sensor calibration and error detection
10835162, Apr 15 2011 DexCom, Inc. Advanced analyte sensor calibration and error detection
10842420, Sep 26 2012 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
10980461, Nov 07 2008 DexCom, Inc. Advanced analyte sensor calibration and error detection
11000215, Nov 07 2008 DEXCOM, INC Analyte sensor
11013439, Sep 30 2008 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
11020031, Nov 07 2008 DEXCOM, INC Analyte sensor
11202592, Sep 30 2008 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
11207005, Oct 30 2009 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
11272890, Nov 10 2008 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
11282603, Oct 25 2006 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
11331022, Oct 24 2017 DexCom, Inc. Pre-connected analyte sensors
11350862, Oct 24 2017 DexCom, Inc. Pre-connected analyte sensors
11382540, Oct 24 2017 DEXCOM, INC Pre-connected analyte sensors
11406331, Oct 31 2011 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
11464430, Jan 29 2009 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
11464434, Sep 30 2008 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
11478173, Jun 29 2010 Abbott Diabetes Care Inc. Calibration of analyte measurement system
11484234, Sep 30 2008 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
11627900, Nov 07 2008 DexCom, Inc. Analyte sensor
11678848, Nov 10 2008 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
11706876, Oct 24 2017 DexCom, Inc. Pre-connected analyte sensors
11896371, Sep 26 2012 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
11943876, Oct 24 2017 DEXCOM, INC Pre-connected analyte sensors
9113828, Oct 25 2006 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
9662056, Sep 30 2008 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
9675290, Oct 30 2012 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
9801577, Oct 30 2012 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
9814428, Oct 25 2006 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
9907492, Sep 26 2012 Abbott Diabetes Care Inc Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
9913619, Oct 31 2011 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
Patent Priority Assignee Title
3581062,
3926760,
3949388, Nov 17 1971 Monitron Industries, Inc. Physiological sensor and transmitter
3978856, Mar 20 1975 Heart beat waveform monitoring apparatus
4036749, Apr 30 1975 Purification of saline water
4055175, May 07 1976 Miles Laboratories, Inc. Blood glucose control apparatus
4129128, Feb 23 1977 TAUT, INC , 2571 KANEVILLE ROAD, GENEVA, COUNTY KANE, ILLINOIS, A DE CORP Securing device for catheter placement assembly
4245634, Dec 11 1975 Hospital For Sick Children Artificial beta cell
4327725, Nov 25 1980 ALZA Corporation Osmotic device with hydrogel driving member
4344438, Aug 02 1978 The United States of America as represented by the Department of Health, Optical sensor of plasma constituents
4349728, Dec 07 1978 LOMAH ELECTRONIC TARGETRY, INC , 333 KEY PALM ROAD, BOCA RATON, FL A CORP OF FL Target apparatus
4373527, Apr 27 1979 The Johns Hopkins University Implantable, programmable medication infusion system
4392849, Jul 27 1981 The Cleveland Clinic Foundation Infusion pump controller
4425920, Oct 24 1980 Purdue Research Foundation Apparatus and method for measurement and control of blood pressure
4462048, Feb 11 1982 RCA Corporation Noise reduction circuitry for audio signals
4478976, Sep 25 1981 BASF Aktiengesellschaft Water-insoluble protein material, its preparation and its use
4494950, Jan 19 1982 The Johns Hopkins University Plural module medication delivery system
4509531, Jul 28 1982 AVIONICS SPECIALTIES, INC Personal physiological monitor
4527240, Dec 29 1982 RELONIX, INC Balascopy method for detecting and rapidly evaluating multiple imbalances within multi-parametric systems
4538616, Jul 25 1983 Blood sugar level sensing and monitoring transducer
4619793, Apr 29 1982 Ciba-Geigy Corporation Method of producing annealed polyvinyl alcohol contact lens
4671288, Jun 13 1985 The Regents of the University of California Electrochemical cell sensor for continuous short-term use in tissues and blood
4703756, May 06 1986 Regents of the University of California, The Complete glucose monitoring system with an implantable, telemetered sensor module
4731726, May 19 1986 Roche Diabetes Care, Inc Patient-operated glucose monitor and diabetes management system
4749985, Apr 13 1987 United States of America as represented by the United States Department Functional relationship-based alarm processing
4757022, Sep 10 1985 DEXCOM, INC Biological fluid measuring device
4777953, Feb 25 1987 ASH ACCESS TECHNOLOGY, INC Capillary filtration and collection method for long-term monitoring of blood constituents
4779618, Aug 10 1984 Pacesetter AB Device and method for the physiological frequency control of a heart pacemaker equipped with a stimulating electrode
4854322, Feb 25 1987 ASH ACCESS TECHNOLOGY, INC Capillary filtration and collection device for long-term monitoring of blood constituents
4871351, Sep 28 1984 Implantable medication infusion system
4890620, Sep 20 1985 The Regents of the University of California Two-dimensional diffusion glucose substrate sensing electrode
4925268, Jul 25 1988 HOSPIRA, INC Fiber-optic physiological probes
4953552, Apr 21 1989 Blood glucose monitoring system
4986271, Jul 19 1989 University of New Mexico Vivo refillable glucose sensor
4995402, Oct 12 1988 Thorne, Smith, Astill Technologies, Inc.; THORNE, SMITH, ASTILL TECHNOLOGIES, INC , 1056 MILLCREST CIRCLE, BOUNTIFUL, UT 84010, A CORP OF DE Medical droplet whole blood and like monitoring
5000180, Aug 03 1988 DRAGER NEDERLAND B V Polarographic-amperometric three-electrode sensor
5002054, Feb 25 1987 Volcano Corporation Interstitial filtration and collection device and method for long-term monitoring of physiological constituents of the body
5019974, May 01 1987 EURUS LLC; DIVA MEDICAL MANAGEMENT SYSTEMS BY Diabetes management system and apparatus
5050612, Sep 12 1989 Device for computer-assisted monitoring of the body
5055171, Oct 06 1986 T AND G CORPORATION A CT CORPORATION Ionic semiconductor materials and applications thereof
5068536, Jan 19 1989 Futrex, Inc. Method for providing custom calibration for near infrared instruments for measurement of blood glucose
5082550, Dec 11 1989 The United States of America as represented by the Department of Energy Enzyme electrochemical sensor electrode and method of making it
5106365, Jun 16 1989 Europhor SA Microdialysis probe
5122925, Apr 22 1991 Control Products, Inc. Package for electronic components
5165407, Apr 19 1990 UNIVERSITY OF KANSAS, THE, Implantable glucose sensor
5231988, Aug 09 1991 LivaNova USA, Inc Treatment of endocrine disorders by nerve stimulation
5246867, Jan 17 1992 LAKOWICZ, JOSEPH R , PH D Determination and quantification of saccharides by luminescence lifetimes and energy transfer
5262035, Aug 02 1989 Abbott Diabetes Care Inc Enzyme electrodes
5262305, Mar 04 1991 THERASENSE, INC Interferant eliminating biosensors
5264104, Aug 02 1989 THERASENSE, INC Enzyme electrodes
5264105, May 08 1992 THERASENSE, INC Enzyme electrodes
5279294, Jul 25 1986 KUDD, ARTHUR R ; DAYTON, JUDSON M Medical diagnostic system
5285792, Jan 10 1992 CREDITANSTALT BANKVEREIN System for producing prioritized alarm messages in a medical instrument
5293877, Dec 11 1991 Covidien AG Body temperature thermometer and method fo measuring human body temperature utilizing calibration mapping
5299571, Jan 22 1993 Disetronic Licensing AG Apparatus and method for implantation of sensors
5320725, Aug 02 1989 THERASENSE, INC Electrode and method for the detection of hydrogen peroxide
5322063, Oct 04 1991 Disetronic Licensing AG Hydrophilic polyurethane membranes for electrochemical glucose sensors
5340722, Aug 24 1988 AVL Medical Instruments AG Method for the determination of the concentration of an enzyme substrate and a sensor for carrying out the method
5342789, Dec 14 1989 SENSOR TECHNOLOGIES, INC Method and device for detecting and quantifying glucose in body fluids
5356786, Mar 04 1991 THERASENSE, INC Interferant eliminating biosensor
5360404, Dec 14 1988 INVIRO MEDICAL DEVICES, INC Needle guard and needle assembly for syringe
5372427, Dec 19 1991 TEXAS INSTRUMENTS INCORPORATED A CORPORATION OF DE Temperature sensor
5376070, Sep 29 1992 MEDTRONIC MINIMED, INC Data transfer system for an infusion pump
5379238, Mar 03 1989 Signal processing method and apparatus
5384547, Aug 02 1993 Motorola Mobility LLC Apparatus and method for attenuating a multicarrier input signal of a linear device
5390671, Mar 15 1994 MEDTRONIC MINIMED, INC Transcutaneous sensor insertion set
5391250, Mar 15 1994 MEDTRONIC MINIMED, INC Method of fabricating thin film sensors
5408999, Oct 23 1992 BRUCE A MCKINLEY Fiber-optic probe for the measurement of fluid parameters
5411647, Nov 23 1992 Disetronic Licensing AG Techniques to improve the performance of electrochemical sensors
5425868, Jul 24 1992 RADIOMETER MEDICAL APS Sensor for non-invasive, in vivo determination of an analyte and blood flow
5431160, Jul 19 1989 University of New Mexico Miniature implantable refillable glucose sensor and material therefor
5431921, Sep 28 1990 Pfizer Inc Dispensing device containing a hydrophobic medium
5462645, Sep 20 1991 Imperial College of Science, Technology & Medicine Dialysis electrode device
5497772, Nov 19 1993 MANN, ALFRED E , FOUNDATION FOR SCIENTIFIC RESEARCH Glucose monitoring system
5507288, May 05 1994 Boehringer Mannheim GmbH Analytical system for monitoring a substance to be analyzed in patient-blood
5509410, Jun 06 1983 MediSense, Inc. Strip electrode including screen printing of a single layer
5514718, Mar 03 1992 ZIMMER, INC Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them
5531878, May 13 1993 The Victoria University of Manchester Sensor devices
5568400, Sep 01 1989 Multiplicative signal correction method and apparatus
5568806, Feb 16 1995 MEDTRONIC MINIMED, INC Transcutaneous sensor insertion set
5569186, Apr 25 1994 MEDTRONIC MINIMED, INC Closed loop infusion pump system with removable glucose sensor
5582184, Oct 13 1993 Integ Incorporated Interstitial fluid collection and constituent measurement
5586553, Feb 16 1995 MEDTRONIC MINIMED, INC Transcutaneous sensor insertion set
5593852, Dec 02 1993 Abbott Diabetes Care Inc Subcutaneous glucose electrode
5609575, Apr 11 1994 Graseby Medical Limited Infusion pump and method with dose-rate calculation
5628310, May 19 1995 LAKOWICZ, JOSEPH R Method and apparatus to perform trans-cutaneous analyte monitoring
5653239, Mar 08 1991 PNC Bank, National Association Continuous temperature monitor
5660163, Nov 19 1993 Alfred E. Mann Foundation for Scientific Research Glucose sensor assembly
5665222, Oct 11 1995 THERASENSE, INC Soybean peroxidase electrochemical sensor
5711001, May 08 1992 Motorola Mobility, Inc Method and circuit for acquisition by a radio receiver
5711861, Nov 22 1995 Legacy Good Samaritan Hospital and Medical Center Device for monitoring changes in analyte concentration
5733259, Jan 31 1992 Gensia Pharmaceuticals, Inc. Method and apparatus for closed loop drug delivery
5772586, Feb 12 1996 Nokia Technologies Oy Method for monitoring the health of a patient
5791344, Nov 19 1993 ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH Patient monitoring system
5899855, Nov 17 1992 HEALTH HERO NETWORK, INC Modular microprocessor-based health monitoring system
5925021, Mar 09 1994 Becton, Dickinson and Company Medication delivery device with a microprocessor and characteristic monitor
5935224, Apr 24 1997 Microsoft Technology Licensing, LLC Method and apparatus for adaptively coupling an external peripheral device to either a universal serial bus port on a computer or hub or a game port on a computer
5942979, Apr 07 1997 On guard vehicle safety warning system
5957854, Sep 04 1993 Body Science LLC Wireless medical diagnosis and monitoring equipment
5964993, Dec 19 1996 TENAX THERAPEUTICS, INC Glucose sensor
5965380, Dec 02 1993 THERASENSE, INC Subcutaneous glucose electrode
5971922, Apr 07 1998 RESEARCH INSTITUTE OF APPLICATION TECHNOLOGIES FOR CHAOS & COMPLEX SYSTEMS CO , LTD System and method for predicting blood glucose level
5995860, Jul 06 1995 Thomas Jefferson University Implantable sensor and system for measurement and control of blood constituent levels
6001067, Mar 04 1997 DEXCOM, INC Device and method for determining analyte levels
6024699, Mar 13 1998 HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR ADMINISTRATIVE AGENT Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients
6049727, Apr 03 1998 Animas Corporation Implantable sensor and system for in vivo measurement and control of fluid constituent levels
6073031, Dec 24 1997 Apple Inc Desktop docking station for use with a wireless telephone handset
6083710, Dec 02 1993 THERASENSE, INC Electrochemical analyte measurement system
6088608, Oct 20 1997 ALFRED E MANN FOUNDATION Electrochemical sensor and integrity tests therefor
6091976, May 09 1996 Roche Diagnostics GmbH Determination of glucose concentration in tissue
6093172, Feb 05 1997 MEDTRONIC MINIMED, INC Injector for a subcutaneous insertion set
6103033, Mar 04 1998 THERASENSE, INC Process for producing an electrochemical biosensor
6117290, Sep 26 1997 Pepex Biomedical, LLC System and method for measuring a bioanalyte such as lactate
6119028, Oct 20 1997 ALFRED E MANN FOUNDATION Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces
6120676, Feb 06 1997 THERASENSE, INC Method of using a small volume in vitro analyte sensor
6121009, Dec 02 1993 THERASENSE, INC Electrochemical analyte measurement system
6121611, May 20 1998 Keysight Technologies, Inc Force sensing probe for scanning probe microscopy
6122351, Jan 21 1997 MED GRAPH, INC Method and system aiding medical diagnosis and treatment
6134461, Mar 04 1998 Abbott Diabetes Care Inc Electrochemical analyte
6143164, Feb 06 1997 ABBOTT DIABETES CARE, INC Small volume in vitro analyte sensor
6162611, Dec 02 1993 THERASENSE, INC Subcutaneous glucose electrode
6175752, Apr 30 1998 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
6200265, Apr 16 1999 Medtronic, Inc.; Medtronic, Inc Peripheral memory patch and access method for use with an implantable medical device
6212416, Nov 22 1995 Legacy Good Samaritan Hospital and Medical Center Device for monitoring changes in analyte concentration
6219574, Jun 17 1997 ALZA Corporation Device and method for enchancing transdermal sampling
6233471, May 13 1998 Lifescan IP Holdings, LLC Signal processing for measurement of physiological analysis
6248067, Feb 05 1999 MEDTRONIC MINIMED, INC Analyte sensor and holter-type monitor system and method of using the same
6275717, Jun 16 1997 Alkermes Pharma Ireland Limited Device and method of calibrating and testing a sensor for in vivo measurement of an analyte
6284478, Dec 02 1993 Abbott Diabetes Care Inc Subcutaneous glucose electrode
6293925, Dec 31 1997 MEDTRONIC MINIMED, INC Insertion device for an insertion set and method of using the same
6295506, Oct 27 1997 RPX Corporation Measurement apparatus
6306104, Dec 06 1996 Abbott Laboratories Method and apparatus for obtaining blood for diagnostic tests
6309884, Feb 26 1997 Dominion Assets, LLC Individual calibration of blood glucose for supporting noninvasive self-monitoring blood glucose
6329161, Dec 02 1993 Abbott Diabetes Care Inc Subcutaneous glucose electrode
6360888, Feb 25 1999 MEDTRONIC MINIMED, INC Glucose sensor package system
6366794, Nov 20 1998 University of Connecticut, The; PRECISION CONTROL DESIGN, INC Generic integrated implantable potentiostat telemetry unit for electrochemical sensors
6377828, Nov 12 1997 LighTouch Medical, Inc. Method for non-invasive measurement of an analyte
6379301, Jan 10 1997 Health Hero Network Diabetes management system and method for controlling blood glucose
6424847, Feb 25 1999 MEDTRONIC MINIMED, INC Glucose monitor calibration methods
6427088, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus and method using telemetry system with predefined reception listening periods
6440068, Apr 28 2000 International Business Machines Corporation Measuring user health as measured by multiple diverse health measurement devices utilizing a personal storage device
6478736, Oct 08 1999 MICROLIFE MEDICAL HOME SOLUTIONS INC Integrated calorie management system
6484046, Mar 04 1998 Abbott Diabetes Care Inc Electrochemical analyte sensor
6514718, Mar 04 1991 TheraSense, Inc. Subcutaneous glucose electrode
6544212, Jul 31 2001 Roche Diabetes Care, Inc Diabetes management system
6551494, Feb 06 1997 Abbott Diabetes Care Inc Small volume in vitro analyte sensor
6558320, Jan 20 2000 MEDTRONIC MINIMED, INC Handheld personal data assistant (PDA) with a medical device and method of using the same
6558321, Mar 04 1997 DEXCOM INC Systems and methods for remote monitoring and modulation of medical devices
6558351, Jun 03 1999 MEDTRONIC MINIMED, INC Closed loop system for controlling insulin infusion
6560471, Jan 02 2001 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
6561978, Feb 12 1999 Lifescan IP Holdings, LLC Devices and methods for frequent measurement of an analyte present in a biological system
6562001, Jan 21 2000 MEDTRONIC MINIMED, INC Microprocessor controlled ambulatory medical apparatus with hand held communication device
6564105, Jan 21 2000 MEDTRONIC MINIMED, INC Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data
6565509, Apr 30 1998 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
6571128, Jan 21 2000 MEDTRONIC MINIMED, INC Microprocessor controlled ambulatory medical apparatus with hand held communication device
6576101, Feb 06 1997 THERASENSE, INC Small volume in vitro analyte sensor
6577899, Jan 21 2000 MEDTRONIC MINIMED, INC Microprocessor controlled ambulatory medical apparatus with hand held communication device
6579690, Dec 05 1997 Abbott Diabetes Care Inc Blood analyte monitoring through subcutaneous measurement
6585644, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
6591125, Jun 27 2000 Abbott Diabetes Care Inc Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
6595919, May 13 1998 Lifescan IP Holdings, LLC Device for signal processing for measurement of physiological analytes
6605200, Nov 15 1999 Abbott Diabetes Care Inc Polymeric transition metal complexes and uses thereof
6605201, Nov 15 1999 Abbott Diabetes Care Inc Transition metal complexes with bidentate ligand having an imidazole ring and sensor constructed therewith
6607509, Dec 31 1997 MEDTRONIC MINIMED, INC Insertion device for an insertion set and method of using the same
6610012, Apr 10 2000 MICROLIFE MEDICAL HOME SOLUTIONS INC System and method for remote pregnancy monitoring
6633772, Aug 18 2000 Lifescan IP Holdings, LLC Formulation and manipulation of databases of analyte and associated values
6635014, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus and method having telemetry modifiable control software
6641533, Aug 18 1998 Medtronic MiniMed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
6648821, Jan 21 2000 MEDTRONIC MINIMED, INC Microprocessor controlled ambulatory medical apparatus with hand held communication device
6654625, Jun 18 1999 Abbott Diabetes Care Inc Mass transport limited in vivo analyte sensor
6659948, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
6668196, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus with hand held communication device
6676816, May 11 2001 Abbott Diabetes Care Inc Transition metal complexes with (pyridyl)imidazole ligands and sensors using said complexes
6687546, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus and method using a robust communication protocol
6689056, Apr 07 1999 Given Imaging LTD Implantable monitoring probe
6694191, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus and method having telemetry modifiable control software
6695860, Nov 13 2000 KONAMITE LIMITED Transcutaneous sensor insertion device
6698269, Apr 27 2001 Oceana Sensor Technologies, Inc. Transducer in-situ testing apparatus and method
6702857, Jul 27 2001 DEXCOM, INC Membrane for use with implantable devices
6733446, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
6740075, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus with hand held communication device
6741877, Mar 04 1997 DEXCOM, INC Device and method for determining analyte levels
6746582, May 12 2000 Abbott Diabetes Care Inc Electrodes with multilayer membranes and methods of making the electrodes
6758810, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus and method using a robust communication protocol
6770030, Sep 17 1999 Device for conducting in vivo measurements of quantities in living organisms
6790178, Sep 24 1999 MICROLIFE MEDICAL HOME SOLUTIONS INC Physiological monitor and associated computation, display and communication unit
6809653, Oct 08 1998 MEDTRONIC MINIMED, INC Telemetered characteristic monitor system and method of using the same
6810290, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus with hand held communication device
6811533, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus and method using a robust communication protocol
6811534, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
6813519, Jan 21 2000 MEDTRONIC MINIMED, INC Ambulatory medical apparatus and method using a robust communication protocol
6862465, Mar 04 1997 DEXCOM, INC Device and method for determining analyte levels
6873268, Jan 21 2000 MEDTRONIC MINIMED, INC Microprocessor controlled ambulatory medical apparatus with hand held communication device
6881551, Mar 04 1991 TheraSense, Inc. Subcutaneous glucose electrode
6892085, Feb 25 1999 Medtronic MiniMed, Inc. Glucose sensor package system
6895263, Feb 23 2000 Medtronic MiniMed, Inc. Real time self-adjusting calibration algorithm
6895265, May 15 2000 Implantable sensor
6931327, Aug 01 2003 DEXCOM, INC System and methods for processing analyte sensor data
6932894, May 15 2001 Abbott Diabetes Care Inc Biosensor membranes composed of polymers containing heterocyclic nitrogens
6936006, Mar 22 2002 Novo Nordisk A S Atraumatic insertion of a subcutaneous device
6950708, Jan 21 2000 Medtronic MiniMed, Inc. Ambulatory medical apparatus and method using a telemetry system with predefined reception listening
6958705, Jan 21 2000 MEDTRONIC MINIMED, INC Microprocessor controlled ambulatory medical apparatus with hand held communication device
6968294, Mar 15 2001 Koninklijke Philips Electronics N.V. Automatic system for monitoring person requiring care and his/her caretaker
6971274, Apr 02 2004 SIERRA INSTRUMENTS, INC Immersible thermal mass flow meter
6974437, Jan 21 2000 MEDTRONIC MINIMED, INC Microprocessor controlled ambulatory medical apparatus with hand held communication device
6990366, Apr 30 1998 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
6997907, Feb 05 1997 Medtronic MiniMed, Inc. Insertion device for an insertion set and method of using the same
6998247, Mar 08 2002 GLT ACQUISITION CORP Method and apparatus using alternative site glucose determinations to calibrate and maintain noninvasive and implantable analyzers
7003336, Feb 10 2000 MEDTRONIC MINIMED, INC Analyte sensor method of making the same
7003340, Mar 04 1998 Abbott Diabetes Care Inc Electrochemical analyte sensor
7003341, Apr 30 1998 Abbott Diabetes Care, Inc. Analyte monitoring devices and methods of use
7022072, Dec 27 2001 MEDTRONICS MINIMED, INC System for monitoring physiological characteristics
7024245, Jan 21 2000 Medtronic MiniMed, Inc. Ambulatory medical apparatus and method using a robust communication protocol
7029444, Feb 23 2000 Medtronic MiniMed, Inc. Real time self-adjusting calibration algorithm
7041068, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Sampling module device and method
7052483, Dec 19 2000 Lifescan IP Holdings, LLC Transcutaneous inserter for low-profile infusion sets
7056302, Feb 26 2002 Ypsomed AG Insertion device for an insertion set and method of using the same
7074307, Jul 25 2003 DexCom, Inc. Electrode systems for electrochemical sensors
7081195, Dec 08 2003 DEXCOM, INC Systems and methods for improving electrochemical analyte sensors
7098803, Oct 08 1998 Medtronic MiniMed, Inc. Telemetered characteristic monitor system and method of using the same
7108778, Jul 25 2003 DEXCOM, INC Electrochemical sensors including electrode systems with increased oxygen generation
7110803, Mar 04 1997 DexCom, Inc. Device and method for determining analyte levels
7113821, Aug 25 1999 Lifescan, Inc Tissue electroperforation for enhanced drug delivery
7134999, Apr 04 2003 DEXCOM, INC Optimized sensor geometry for an implantable glucose sensor
7136689, Mar 04 1997 DexCom, Inc. Device and method for determining analyte levels
7171274, Jan 21 2000 Medtronic MiniMed, Inc. Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data
7190988, Apr 30 1998 SYNTHEON NEUROVASCULAR LLC Analyte monitoring device and methods of use
7192450, May 21 2003 DEXCOM, INC Porous membranes for use with implantable devices
7198606, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with analyte sensing
7226978, May 22 2002 DexCom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
7276029, Aug 01 2003 DEXCOM, INC System and methods for processing analyte sensor data
7299082, Oct 31 2003 Abbott Diabetes Care Inc Method of calibrating an analyte-measurement device, and associated methods, devices and systems
7310544, Jul 13 2004 DexCom, Inc. Methods and systems for inserting a transcutaneous analyte sensor
7317938, Oct 08 1999 GLT ACQUISITION CORP Method of adapting in-vitro models to aid in noninvasive glucose determination
7335294, Feb 06 1997 Abbott Diabetes Care Inc Integrated lancing and measurement device and analyte measuring methods
7354420, Jun 03 1999 Medtronic MiniMed, Inc. Closed loop system for controlling insulin infusion
7364592, Feb 12 2004 DEXCOM, INC Biointerface membrane with macro-and micro-architecture
7366556, Oct 04 2006 DEXCOM, INC Dual electrode system for a continuous analyte sensor
7379765, Jul 25 2003 DEXCOM, INC Oxygen enhancing membrane systems for implantable devices
7402153, Jun 03 1999 Medtronic MiniMed, Inc. Closed-loop method for controlling insulin infusion
7424318, Oct 04 2006 DEXCOM, INC Dual electrode system for a continuous analyte sensor
7460898, Oct 04 2006 DEXCOM, INC Dual electrode system for a continuous analyte sensor
7467003, Dec 05 2003 DEXCOM, INC Dual electrode system for a continuous analyte sensor
7471972, Jul 27 2001 DexCom, Inc. Sensor head for use with implantable devices
7494465, Jul 13 2004 DEXCOM, INC Transcutaneous analyte sensor
7497827, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
7499002, Feb 08 2005 International Business Machines Corporation Retractable string interface for stationary and portable devices
7519408, Nov 19 2003 DEXCOM, INC Integrated receiver for continuous analyte sensor
7547281, Feb 01 2005 MEDTRONICS MINIMED, INC Algorithm sensor augmented bolus estimator for semi-closed loop infusion system
7569030, Sep 07 2001 Medtronic MiniMed, Inc. Safety limits for closed-loop infusion pump control
7583990, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
7591801, Feb 26 2004 DEXCOM, INC Integrated delivery device for continuous glucose sensor
7599726, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
7613491, Apr 14 2006 DEXCOM, INC Silicone based membranes for use in implantable glucose sensors
7615007, Oct 04 2006 DEXCOM, INC Analyte sensor
7618369, Oct 02 2006 ABBOTT DIABETES CARE, INC Method and system for dynamically updating calibration parameters for an analyte sensor
7632228, Jul 27 2001 DexCom, Inc. Membrane for use with implantable devices
7699964, Feb 09 2004 Abbott Diabetes Care Inc Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
20010041831,
20020019022,
20020042090,
20020103499,
20020106709,
20020128594,
20020161288,
20020169635,
20020193679,
20030004403,
20030023317,
20030032874,
20030042137,
20030050546,
20030065308,
20030100821,
20030125612,
20030130616,
20030134347,
20030168338,
20030176933,
20030187338,
20030191377,
20030199790,
20030208113,
20030212317,
20030212379,
20030216630,
20030217966,
20040010207,
20040011671,
20040039298,
20040040840,
20040045879,
20040064068,
20040099529,
20040106858,
20040122353,
20040133164,
20040138588,
20040146909,
20040152622,
20040167801,
20040171921,
20040176672,
20040186362,
20040186365,
20040193025,
20040193090,
20040197846,
20040199059,
20040204687,
20040208780,
20040225338,
20040236200,
20040254433,
20040263354,
20040267300,
20050003470,
20050004439,
20050004494,
20050010087,
20050010269,
20050016276,
20050027177,
20050031689,
20050038332,
20050043598,
20050090607,
20050096511,
20050096512,
20050112169,
20050113653,
20050114068,
20050121322,
20050131346,
20050143635,
20050176136,
20050177398,
20050182306,
20050187720,
20050192557,
20050195930,
20050199494,
20050203360,
20050239154,
20050241957,
20050245795,
20050245799,
20050245839,
20050245904,
20050287620,
20060001538,
20060004270,
20060015020,
20060015024,
20060016700,
20060019327,
20060020186,
20060020187,
20060020188,
20060020189,
20060020190,
20060020191,
20060020192,
20060029177,
20060031094,
20060036139,
20060036140,
20060036141,
20060036142,
20060036143,
20060036144,
20060036145,
20060155180,
20060166629,
20060173260,
20060173406,
20060173444,
20060183985,
20060189863,
20060222566,
20060224109,
20060226985,
20060229512,
20060247508,
20060272652,
20060281985,
20070016381,
20070027381,
20070032706,
20070033074,
20070060803,
20070060814,
20070071681,
20070073129,
20070078320,
20070078321,
20070078322,
20070078323,
20070106135,
20070118405,
20070124002,
20070149875,
20070163880,
20070168224,
20070173706,
20070173761,
20070179349,
20070179352,
20070191701,
20070203407,
20070203966,
20070213657,
20070232877,
20070235331,
20070249922,
20080009692,
20080017522,
20080021666,
20080029391,
20080033254,
20080039702,
20080045824,
20080058625,
20080064937,
20080071156,
20080071157,
20080071158,
20080081977,
20080083617,
20080086042,
20080086044,
20080086273,
20080097289,
20080108942,
20080119708,
20080154513,
20080167543,
20080172205,
20080183060,
20080183061,
20080183399,
20080188731,
20080188796,
20080189051,
20080194935,
20080194936,
20080194937,
20080194938,
20080195232,
20080195967,
20080197024,
20080200788,
20080200789,
20080200791,
20080208025,
20080208113,
20080214915,
20080214918,
20080228051,
20080228054,
20080242961,
20080255434,
20080255437,
20080255808,
20080256048,
20080262469,
20080275313,
20080287761,
20080287762,
20080287763,
20080287764,
20080287765,
20080287766,
20080288180,
20080288204,
20080296155,
20080306368,
20080306434,
20080306435,
20080306444,
20080312841,
20080312842,
20080312844,
20080312845,
20080314395,
20080319279,
20090005665,
20090006034,
20090012379,
20090018424,
20090030294,
20090033482,
20090036747,
20090036758,
20090036760,
20090036763,
20090043181,
20090043182,
20090043525,
20090043541,
20090043542,
20090045055,
20090055149,
20090062633,
20090062635,
20090062767,
20090063402,
20090069649,
20090076356,
20090076360,
20090076361,
20090099436,
20090105636,
20090124877,
20090124878,
20090124879,
20090124964,
20090131768,
20090131769,
20090131776,
20090131777,
20090137886,
20090137887,
20090143659,
20090143660,
20090156919,
20090156924,
20090163790,
20090163791,
20090164190,
20090164239,
20090164251,
20090178459,
20090182217,
20090192366,
20090192380,
20090192722,
20090192724,
20090192745,
20090192751,
20090198118,
20090203981,
20090204341,
20090216103,
20090240120,
20090240128,
20090240193,
20090242399,
20090242425,
20090247855,
20090247856,
20090247857,
20090287073,
20090287074,
20090299155,
20090299156,
20090299162,
20090299276,
20100057040,
20100057041,
20100057042,
20100057044,
20100057057,
CA2667930,
DE4401400,
EP98592,
EP127958,
EP286118,
EP320109,
EP353328,
EP390390,
EP396788,
EP1048264,
WO49940,
WO59370,
WO74753,
WO78992,
WO152935,
WO154753,
WO2058537,
WO216905,
WO3076893,
WO3082091,
WO3085372,
WO2004060455,
WO2004061420,
WO2005041766,
WO2005065542,
WO2005089103,
WO2006024671,
WO2006079114,
WO2006086423,
WO2006118947,
WO2006124099,
WO2007016399,
WO2007027788,
WO2007041069,
WO2007041070,
WO2007041072,
WO2007041248,
WO2007053832,
WO2007056638,
WO2007101223,
WO2007115094,
WO2007120363,
WO2007126444,
WO2007143225,
WO2008042760,
WO2008128210,
WO2008130896,
WO2008130897,
WO2008130898,
WO2008143943,
WO2009018058,
WO2009086216,
WO2009096992,
WO2009097594,
WO9625089,
WO9635370,
WO9835053,
WO9956613,
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jan 04 2007BUDIMAN, ERWIN S ABBOTT DIABETES CARE, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0229790161 pdf
Jul 20 2009Abbott Diabetes Care Inc.(assignment on the face of the patent)
Date Maintenance Fee Events
Dec 29 2015M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Dec 18 2019M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Dec 14 2023M1553: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Jul 10 20154 years fee payment window open
Jan 10 20166 months grace period start (w surcharge)
Jul 10 2016patent expiry (for year 4)
Jul 10 20182 years to revive unintentionally abandoned end. (for year 4)
Jul 10 20198 years fee payment window open
Jan 10 20206 months grace period start (w surcharge)
Jul 10 2020patent expiry (for year 8)
Jul 10 20222 years to revive unintentionally abandoned end. (for year 8)
Jul 10 202312 years fee payment window open
Jan 10 20246 months grace period start (w surcharge)
Jul 10 2024patent expiry (for year 12)
Jul 10 20262 years to revive unintentionally abandoned end. (for year 12)